Clinical Trials Update: Oct. 16, 2007
Neurologic Disorders
Diabetic Neuropathy
Migraine (Pediatric)
|
E-mail this article
Subscribe to news
Printer friendly version
|
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Neurologic Disorders
Many people at risk of cognitive decline are not able to make visits to a medical clinic, due to factors such as lack of transportation, impaired mobility, and cost. This study will assess ways to evaluate cognitive function at a person's residence. Participants must be 75 or older, and additional criteria apply.
The research site is in Sun City, Ariz.
More information
Please see http://www.centerwatch.com/patient/studies/cat278.html 
.
-----
Diabetic Neuropathy
This eight-month study will evaluate an investigational medication for diabetic neuropathy. You must be diabetic and 18 or older to qualify. Participants will receive study related medical care and investigational medication at no cost, and may be compensated for time and travel.
The research site is in Dallas, Texas.
More information
Please see http://www.centerwatch.com/patient/studies/cat253.html .
-----
Migraine (Pediatric)
If you have a child aged 12 to 17 who has migraine headaches, the child may be eligible to participate in a study evaluating an investigational combination of two medications. Participants will receive study related exams and study medications at no cost, and may be compensated for time and travel.
The research site is in San Antonio, Texas.
More information
Please see http://www.centerwatch.com/patient/studies/cat440.html .
-----
Copyright 2007 Thomson CenterWatch . All rights reserved.
Copyright © 2007 ScoutNews, LLC. All rights reserved. 
HealthDayNews articles are derived from various sources and do not reflect federal policy. healthfinder.gov does not endorse opinions, products, or services that may appear in news stories. For more information on health topics in the news, visit the healthfinder.gov health library.